Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kedalion Therapeutics logo — Experience precise, efficient, and comfortable ocular drug d...

Kedalion Therapeutics

Experience precise, efficient, and comfortable ocular drug delivery with our innovative digital platform, reducing doses by up to 80%.

Founded 2015 Series B Total: $5.00M Biotechnology, Health Care +1

General Information

Company Name Kedalion Therapeutics
Founded Year 2015
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Kedalion Therapeutics. To contact Kedalion Therapeutics, visit kedalionthera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Kedalion Therapeutics

Kedalion Therapeutics is a biotechnology company established in 2015, focusing on cutting-edge topical ophthalmic treatments. The company's AcuStream platform revolutionizes ocular drug delivery, offering precise and efficient therapy while reducing doses by up to 80%. This digitally connected, electromechanical device caters to the demand for a more user-friendly and convenient instrument that ensures reliable, accurate, and comfortable treatment. The latest milestone in Kedalion's journey is the Series B investment secured on 15 November 2021, with prominent participation from Novartis Venture Fund and Lagunita Biosciences. The company operates in the Biotechnology, Health Care, Health, and Wellness industries, aiming to address new and existing medical needs with its innovative solutions.

Taxonomy: ocular drug delivery, ophthalmic treatments, topical medications, AcuStream platform technology, electromechanical device, digital platform, precision medicine, innovation, patient comfort, startup, investing

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 2
Novartis Venture Fund Lagunita Biosciences
Novartis Venture Fund, Lagunita Biosciences
15 Nov 2021
Series A $5.00M 1
Lagunita Biosciences
Lagunita Biosciences
06 Aug 2018

Kedalion Therapeutics Alternatives & Competitors

View All Alternatives
Kedalion Therapeutics vs
Re-Vana Therapeutics
Re-Vana Therapeutics United Kingdom

To advance the quality of care for patients suffering from sight-threatening diseases.

Series A
24 employees
Health Care, Health and Wellness
Kedalion Therapeutics vs
Hemispherian AS
Hemispherian AS Norway

Hemispherian is a biotechnology company developing new treatments for the most aggressive types of c...

Grant
10 employees
Biotechnology, Health Care
Kedalion Therapeutics vs
Cerebral Therapeutics, Inc.
Cerebral Therapeutics, Inc. United States

A clinical stage pharmaceutical company developing innovative treatments for neurological disease.

Series C
22 employees
Biotechnology, Health Care
View all alternatives

FAQ About Kedalion Therapeutics

Experience precise, efficient, and comfortable ocular drug delivery with our innovative digital platform, reducing doses by up to 80%.
Kedalion Therapeutics was founded in 2015.
Kedalion Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on ocular drug delivery, ophthalmic treatments, topical medications and AcuStream platform technology.
Kedalion Therapeutics has completed 2 funding rounds, raising a total of $5.00M. The latest funding stage is Series B.
Top alternatives and competitors to Kedalion Therapeutics include Re-Vana Therapeutics, Hemispherian AS, Cerebral Therapeutics, Inc., Ocular Therapeutix, Inc., Olympic Ophthalmics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kedalion Therapeutics and Re-Vana Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kedalion Therapeutics, https://bouncewatch.com/company/kedalion-therapeutics, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes